Josie Hasan, 36, from Plymouth, is a doting mum to her girls, Becca, nine, and Sophie, six. Josie was diagnosed with stage 3c ...

Josie Hasan, 36, from Plymouth, is a doting mum to her girls, Becca, nine, and Sophie, six. Josie was diagnosed with stage 3c ...

Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that the first ...

The B-cell inhibitors market is experiencing robust growth, driven by the rising prevalence of the addressable patient population, which incl ...

Discover key insights from Roivant Sciences' Q4 2024 earnings call. Learn about their robust pipeline, pivotal 2025 milestones, and capital strength.

Prominently featured in The Inner Circle, Amishi Bajaj, MD is acknowledged as a Top Pinnacle Professional for her contributions to Advancing Cancer Care Through Compassionate, Innovative Treatment. Dr ...

Myasthenia Gravis Foundation of America (MGFA™), the largest, leading patient advocacy organization in the United States ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- What Does The C5 Complement Inhibitors Market Landscape Look Like? The market for C5 complement inhibitors, critical ...

On May 27, RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in China by the National Medical Products Administration (NMPA) for the ...

TG Therapeutics is on track to beat expectations with Briumvi, its fast-growing, best-in-class MS treatment. Find out why ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.